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Oral iron administration in African children can increase the risk for infections. However,
it remains unclear to what extent supplementary iron affects the intestinal microbiome.
We here explored the impact of iron preparations on microbial growth and metabolism
in the well-controlled TNO’s in vitro model of the large intestine (TIM-2). The model
was inoculated with a human microbiota, without supplementary iron, or with 50 or
250µmol/L ferrous sulfate, 50 or 250µmol/L ferric citrate, or 50µmol/L hemin. High
resolution responses of the microbiota were examined by 16S rDNA pyrosequencing,
microarray analysis, and metagenomic sequencing. The metabolome was assessed
by fatty acid quantification, gas chromatography-mass spectrometry (GC-MS), and
1H-NMR spectroscopy. Cultured intestinal epithelial Caco-2 cells were used to assess
fecal water toxicity. Microbiome analysis showed, among others, that supplementary iron
induced decreased levels of Bifidobacteriaceae and Lactobacillaceae, while it caused
higher levels of Roseburia and Prevotella. Metagenomic analyses showed an enrichment
of microbial motility-chemotaxis systems, while the metabolome markedly changed from
a saccharolytic to a proteolytic profile in response to iron. Branched chain fatty acids and
ammonia levels increased significantly, in particular with ferrous sulfate. Importantly, the
metabolite-containing effluent from iron-rich conditions showed increased cytotoxicity
to Caco-2 cells. Our explorations indicate that in the absence of host influences, iron
induces a more hostile environment characterized by a reduction of microbes that are
generally beneficial, and increased levels of bacterial metabolites that can impair the
barrier function of a cultured intestinal epithelial monolayer.
Keywords: in vitro fermentation, iron supplementation, gut microbiome, metabolome, metagenome, toxicity,
SCFA, BCFA
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INTRODUCTION
Iron deficiency is the most prevalent nutritional disorder
worldwide, mostly affecting infants, young children, and women
in developing countries. This deficiency has major health
consequences such as poor pregnancy outcome, and impaired
physical and cognitive development of children (WHO and
UNICEF, 2004; Muthayya et al., 2013). Several trials have shown
that iron deficiency can be effectively controlled by oral iron
administration (Zimmermann and Hurrell, 2007). However,
the uptake of iron from the intestines is influenced by many
factors and is usually limited (Hurrell and Egli, 2010). Iron
supplementation therefore generally results in a large fraction of
unabsorbed iron entering the colon, being potentially available
for the gut microbiota.
Importantly, oral iron administration is known to increase
the incidence of diarrhea and has been associated with increased
gut inflammation (Gera and Sachdev, 2002; Zimmermann et al.,
2010; Jaeggi et al., 2014). It is therefore highly warranted to
investigate the effects of nutritional iron on the gut microbiota
composition and metabolic activity. We previously showed
that iron can enhance the growth and virulence of gut
bacterial pathogens in pure cultures (Kortman et al., 2012).
Furthermore, it was recently shown that iron fortification
caused a potentially more pathogenic gut microbiota profile (i.e.,
increased relative abundance of Enterobacteriaceae, including
pathogenic Escherichia coli, and a decrease of generally beneficial
Lactobacillaceae and/or Bifidobacteriaceae) in African children
and infants (Zimmermann et al., 2010; Jaeggi et al., 2014). This
increase in the abundance of fecal Enterobacteriaceae correlated
with an increase of fecal calprotectin (Zimmermann et al.,
2010), which is a marker of gut inflammation. Notably, the
reported effect of oral iron administration on the gut microbiota
composition varies between studies. The most consistent
outcome of iron supplementation appears to be a decrease in
Lactobacillaceae and Bifidobacteriaceae, and an increase in E.
coli (Mevissen-Verhage et al., 1985; Balmer et al., 1989; Balmer
and Wharton, 1991; Benoni et al., 1993; Tompkins et al., 2001;
Lee et al., 2008; Zimmermann et al., 2010; Werner et al., 2011;
Dostal et al., 2012a,b, 2014b; Krebs et al., 2013; Jaeggi et al., 2014;
Kortman et al., 2014). The large variation in the effects of iron on
the gut microbiota composition in humans and animals may be
explained by differences in experimental models, and host factors
such as iron status, intestinal immune function, dietary habits
and the environmental setting. Importantly, in vitro models of
the colon allow the reproducible testing of the effects of iron
on the microbiota in isolation, by eliminating any influence of
the host. On the other hand, the most important limitation is
the absence host feedback mechanisms that normally influence
microbiota composition and activity (Sekirov et al., 2010; Hooper
et al., 2012). Also inoculum preparation from feces influences
the microbiota. It should be noted that colon models can never
establish intestinal conditions identical to those in the host.
Therefore, inoculum preparation and inoculation in the model
will always result in a newly balanced microbiota. Although these
in vitromodels have their limitations, they have also been shown
to closely mimic the in vivo situation in terms of microbial
composition and metabolism (Payne et al., 2012; Venema and
van den Abbeele, 2013).
Besides the intestinal microbiota composition, the bacterial
metabolic activity is also important for gut health. For example,
indigestible food components can be metabolized into the
main Short Chain Fatty Acids (SCFAs) acetate, propionate and
butyrate. These, and especially butyrate, are beneficial for gut
health, for example by providing energy to colonocytes and by
exerting anti-inflammatory effects (Macfarlane and Macfarlane,
2011). In contrast, protein fermentation can result in toxic
or potentially toxic metabolites such as ammonia, Branched
Chain Fatty Acids (BCFAs) (e.g., isobutyrate and isovalerate),
and phenolic compounds (Macfarlane and Macfarlane, 2012;
Nyangale et al., 2012). Although the mechanisms of action
remain unknown so far, it has recently been shown that
iron can influence bacterial metabolic activity (Dostal et al.,
2012a,b, 2014b). The in vivo levels of butyrate and propionate
were lower during luminal iron deficiency in rats, which
could be restored by iron repletion (Dostal et al., 2012a). In
vitro, butyrate and propionate production were most clearly
impaired during very low iron conditions, while conversely, the
production of these SCFAs was not stimulated by high iron
conditions. The production of BCFAs as a result of protein
fermentation was decreased under low iron conditions, but in
contrast to the production of SCFAs, this proteolytic activity
did increase under high iron conditions (Dostal et al., 2012b).
Interestingly, a recent study in rats showed that supplementary
iron increased cecal SCFA levels not only when compared to
an iron-deficient diet, but also when compared to a control
diet (Dostal et al., 2014b). However, the latter rat study did
not specifically report on the production of BCFAs. Together,
these studies suggest that iron supplementation may have health-
promoting effects via an increase in microbial SCFA production,
but potentially also deleterious effects by increasing toxic protein
fermentation. Thus, the net effects of iron preparations on gut
microbial metabolism remain inconclusive and need further
exploration with both a targeted and metabolomic approach.
In the present study we explore the effect of multiple iron
sources and doses; i.e., 50 or 250µmol/L ferrous sulfate, 50
or 250µmol/L ferric citrate, or 50µmol/L hemin, on the
composition and metabolic activity of a microbiota that is
representative for the in vivo human gut microbiota. To mimic
the human in vivo conditions, we use the well-suited and
highly controlled TNO’s Intestinal Model 2 (TIM-2) for the
human large intestine (Minekus et al., 1999; Maathuis et al.,
2009).
RESULTS
The Influence of Iron on the Microbiota
Composition
The microbiota composition was analyzed by 16S rDNA
sequencing, microarray (I-Chip), and metagenomic sequencing.
The main results are shown below, and are complemented
by information on total bacteria and microbiota diversity
in Supplementary Data 2. With a microbial density of
Frontiers in Microbiology | www.frontiersin.org 2 January 2016 | Volume 6 | Article 1481
Kortman et al. Iron-induced Gut Microbial Metabolome Toxicity
approximately 4 × 109 cells/g in the TIM-2 model, it closely
reflects the densities found in the proximal colon (1010–1011),
whereas microbial densities in feces are generally about two
orders of magnitude higher (Payne et al., 2012).
Microbiome Analysis by 16S rDNA Sequencing
We determined the microbiome composition by analyzing on
average 3445 bacterial 16S rDNA sequences per sample, obtained
by pyrosequencing. Multivariate redundancy analysis (RDA)
showed that the different iron levels resulted in a distinct non-
overlapping microbiota composition (p = 0.040; Figure 1A),
while iron supplementation as ferrous sulfate (FeS) or ferric
citrate (FeC) resulted in a similar microbiota profile, but that was
distinct from that of the endogenous iron (lowFe) and hemin
(FeH) conditions (p = 0.032; Figure 1C). The main differences
between the microbiome of the lowFe controls and the
conditions with mediumFe and highFe at 72 h are summarized
in Figures 2A,B, respectively. These analyses revealed that the
genera Lactobacillus, Bifidobacterium, and Streptococcuswere less
abundant in the mediumFe and highFe conditions compared
to the lowFe controls and that Roseburia and Coprococcus,
and to a lesser extent, Prevotella were more abundant in the
FIGURE 1 | Multivariate redundancy analysis (RDA) of the microbiota composition. The conditions were grouped at iron level: low (endogenous Fe; n = 4),
medium (pooled 50FeS and 50FeC conditions; n = 8), high (pooled 250FeS and 250FeC conditions; n = 8) and hemin (50µmol/L hemin; n = 4). RDA was performed
using Canoco 5.0. Taxonomic composition at the genus level was used as response data, iron level as explanatory variable, time point and experiment as
supplementary variables. The variation explained by the ordination axis is significantly higher than random (p = 0.04; permutation test). Total variation explained was
33.3% (A,B). To study differences between iron sources, conditions were grouped at iron source: low (n = 4), sulfate (pooled 50FeS and 250FeS; n = 8), citrate
(pooled 50FeC and 250FeC; n = 8), and hemin (n = 4). Taxonomic composition at the genus level was used as response data, iron source as explanatory variable,
time point, and experiment as supplementary variables. The variation explained by the ordination axis is significantly higher than random (p = 0.032; permutation test).
Total variation explained was 32.5% (C,D). Red symbols represent iron level or iron source classes, light green samples the two replicate experiments and dark green
symbols the two time points. Open symbols are the individual samples. The colored lines are envelopes connecting samples of the same iron level or iron source.
Length of arrows reflects significance. Classified sample diagrams in (A,C), Taxa—metadata biplots in (B,D).
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FIGURE 2 | Differences in gut microbial composition between the lowFe control and the medium and high Fe and conditions at 72h. Nodes represent
taxa; edges link the different taxonomic levels. The fold difference is calculated as the 2log of the ratio of the relative abundance in the lowFe (n = 2) and mediumFe
(n = 4) conditions (A) or in the lowFe and highFe (n = 4) conditions (B) (0, no difference between groups; 1, twice as abundant in mediumFe/highFe, etc.). In this
explorative analysis, the significance is expressed as the p-value of a Mann–Whitney U-test. The node-size corresponds to the relative abundance. Taxa (that is,
nodes) were included in this visualization when the fold difference met a significance level of p < 0.1, or when the taxon had a child (that is, more specific taxonomic
classification) meeting this criterion. 1 Phascolarctobacterium was not detected within the lowFe condition and has therefore an estimated 2log fold difference of 10.
mediumFe and highFe conditions. This is consistent with the
outcome of the RDA, where these same taxa separated the lowFe
from the mediumFe and highFe conditions (Figures 1B,D).
Differences between the mediumFe and highFe conditions and
differences between the lowFe and FeH conditions are shown in
Supplementary Figure 5.
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Microbiome Analysis by I-Chip and Metagenomic
Sequencing
To support and validate the data from 16S rDNA sequencing, we
investigated the changes of taxa over time and the effects of iron
on certain species by using an I-Chip microarray platform for the
analysis of the microbial community in the TIM-2 lumen at every
time point (0, 24, 48, and 72h). Moreover, shotgun metagenomic
sequencing allowed taxonomic analysis of the duplicate samples
of lowFe and 50FeS at 72 h, this was also used to support the 16S
rDNA sequencing data.
In both the I-Chip and metagenomic datasets, Prevotella was
markedly higher in all conditions with supplementary iron at
72 h. I-Chip data furthermore showed that Prevotella generally
increased in the conditions with iron with a small decrease
after 48 h, while its levels remained relatively low and stable
in the lowFe condition. Metagenomic analysis also showed that
Prevotella levels were higher in 50FeS compared to lowFe at
72 h (2log ratio: 7.07; p = 0.006; Supplementary Figure 6).
Next, I-Chip analysis showed a gradual increase of Roseburia
in the 50FeS, 250FeS, and 50FeC conditions and metagenomic
analysis confirmed that specifically Roseburia intestinalis was
more abundant at 72 h in 50FeS compared to lowFe (2log
ratio: 2.01; p = 0.073; Supplementary Tables 1, 2). 16S rDNA
sequencing showed that the sulfate-reducing bacteria (SRB)
member Desulfovibrionales (order) was more abundant in the
conditions with iron at 72 h (Figures 2A,B). This is consistent
with the metagenomic analysis, where the genus Desulfovibrio
(2log ratio: 3.08; p = 0.042) and specifically the species D.
desulfuricans (2log ratio: 3.66; p = 0.043) andD. piger (2log ratio:
1.33; p = 0.030) were more abundant in the 50FeS condition
compared to lowFe (Supplementary Table 2). Interestingly,
although genus Bacteroides as a group was not significantly
more abundant in the iron groups, several Bacteroides spp.
were significantly more abundant in 50FeS compared to lowFe,
including the opportunistic pathogen Bacteroides fragilis (2log
ratio: 1.79; p = 0.029), which was also apparent from the I-
Chip analysis, mainly for the FeS conditions (Supplementary
Tables 1, 2).
The metagenomic shotgun sequencing also detected
sequences from outside the bacterial domain, including
Archaea, Eukaryota, and a small minority of viral sequences.
Archaea as a group were relatively more abundant in the
50FeS group than in the lowFe group at 72 h (2log ratio:
4.90; p = 0.095). Specific Archaea members that were
more abundant included Methanosphaera (2log ratio: 6.49;
p = 0.001), Methanobrevibacter (2log ratio: 7.27; p = 0.091) and
Methanobacteria (2log ratio: 7.24; p = 0.093; Supplementary
Table 2).
The Influence of Iron on the Microbial
Metabolome
Iron is involved in many metabolic processes and is indeed
known to influence gut bacterial metabolism, such as the
production of SCFAs. Iron-induced changes in the gut microbial
composition may also affect gut microbial metabolic activity.
Therefore, it is important to explore the effects of supplementary
iron on the gut microbial metabolome.
Short Chain Fatty Acid and Branched Chain Fatty
Acid levels
To study the effect of iron on the production of the main SCFA
and BCFA, the cumulative amounts of these metabolites were
determined in the lumen and dialysate. Analysis showed that
there was no significant effect of iron supplementation on acetate
production. However, propionate production was doubled in
highFe compared to lowFe (p < 0.05) and propionate levels
were also significantly higher in highFe compared to mediumFe
(p < 0.05). Butyrate production was similar in all conditions,
but was lowest in FeH, which was different from mediumFe
(p < 0.05; Table 1). Iron source had no significant impact on
SCFA levels, except for a lower butyrate level in FeH compared to
FeC (Table 1). Although the absolute valerate content was low
compared to the other SCFAs, it showed a significant increase
under 250FeS compared to lowFe (p < 0.05). The valerate level in
250FeS was also significantly higher than in FeH and 50FeC (p <
0.05 for both;Table 1). BCFA production wasmarkedly increased
in FeS compared to lowFe and FeH, and also compared to FeC (all
p < 0.05), which implies that ferrous sulfate stronger stimulated
protein fermentation compared to ferric citrate. Interestingly,
iron level (medium vs high) had no significant impact on BCFA
levels (Table 1).
Ammonia Levels
Ammonia, a toxic metabolite that originates from protein
breakdown, was determined in the lumen and dialysate of TIM-
2. Similar to BCFAs, the cumulative ammonia level was increased
in all iron conditions and most prominently in the ferrous sulfate
conditions. When iron levels were pooled, the ammonia level was
higher in both mediumFe and highFe than in lowFe (p < 0.05;
Table 1). Interestingly, when the iron sources were pooled, only
the ferrous sulfate pool showed a significantly higher ammonia
level than lowFe (p < 0.05), but the ferrous sulfate pool was not
significantly different from the ferric citrate pool (Table 1).
1H-NMR-Spectroscopy and Organic Acid Analysis
1H-NMR spectroscopy and GC-MS organic acid analysis were
used to explore the microbial metabolome in the dialysate. 1H-
NMR spectroscopy detected a total of 26 metabolites, of which
20 could be identified and quantified (Supplementary Table 3).
Moreover, nine organic acid metabolites could be identified and
relatively quantified by GC-MS organic acid analysis. A main
effect of iron supplementation was the sharp decrease of lactate
compared to the lowFe control (p < 0.05), which was detected
with both GC-MS and 1H-NMR techniques (Table 1). Another
abundant metabolite that mainly derives from carbohydrate
fermentation, was succinate. Compared to lowFe, succinate
content was higher in FeH and 50FeC (p < 0.05 for both).
Remarkably, the succinate level was higher in 50FeC compared
to 50FeS (p < 0.05), but was almost absent in both high-iron
conditions, with a large difference between 50FeC and 250FeC
(p < 0.01; Table 1).
Part of a 1H-NMR spectrum is depicted in Figure 3
where lowFe and 250FeS are compared. 1H-NMR spectroscopy
thus confirms the increase in valerate as mentioned above.
This technique also revealed an almost equal decrease of
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FIGURE 3 | 500 MHz 1H-NMR spectra (regions 2.7–0.5 ppm and 8.5–8.0 ppm) of dialysate samples. 1H-NMR spectroscopy at pH 2.50 of the lowFe
condition (upper panel) and 250FeS condition (lower panel) at 72h showed that the SCFAs butyrate and acetate were similar in both conditions, while propionate
content was slightly higher in 250FeS. Lactate and ethanol disappeared in the iron condition, while valerate content showed the opposite effect (see also Table 1).
Peak assignments: butyrate (1, 6, and 8), propionate (2 and 9), ethanol (3), lactate (4), alanine (5), acetate (7), formate (10), valerate (11, 13, and 15) isobutyrate (12)
and isovalerate (14). # increased in the condition with iron; *decreased in the condition with iron. Of both conditions one replicate is shown, which were representative
for their duplicate. Also, the results of the 1H-NMR method correlate well with the results of both the GC-MS organic acid analysis and the SCFA/BCFA GC-method.
approximately four-fold in formate content for all iron-
supplemented conditions (250FeC not assessed) compared to
lowFe (p < 0.001; Table 1). Further, metabolite profiling showed
a decrease in ethanol content in both ferrous sulfate conditions
compared to lowFe (both p < 0.01) and also when compared to
FeH and 50FeC (both p < 0.05; Table 1).
Among the organic acids identified, most were aromatic
amino acid or polyphenol-derived and they generally showed an
increase upon iron supplementation. Phenylpropionate content
tended to be higher in both ferrous sulfate conditions, and
also in the ferric citrate conditions (not significant; Figure 4A).
Phenylacetate levels appeared to be higher 50FeS and 250FeS
compared to lowFe, but it was not detected in 50FeC and 250FeC
(Figure 4A). 4-Hydroxy-phenylpropionate content was mainly
increased in both ferrous sulfate conditions (not significant;
Figure 4A). Although only in small amounts, 3-hydroxy-
phenylpropionate was exclusively detected in 250FeS and was
considered to be absent in all other conditions (data not shown).
Although none of these effects were statistically significant, they
support our findings that proteolytic activity is stimulated by iron
supplementation.
Siderophoric Metabolites Detected by Organic Acid
Analysis
Other amino acid-derived metabolites were categorized as
compounds with siderophore activity. 2-Hydroxy-isovalerate
was only detected in substantial amounts in the dialysate of
lowFe and FeH (Figure 4B). 2-Hydroxy-isocaproate content
showed a similar pattern and was significantly lower in the
pooled ferrous sulfate, the pooled ferric citrate, the pooled
mediumFe and the pooled highFe conditions compared to
lowFe and FeH (all p < 0.05). Phenyllactate content was
relatively variable within the biological duplicates, nevertheless
it was exclusively below the detection limit in all ferrous sulfate
replicates and also in 250FeC (Figure 4B). These data support a
potential siderophore function of these metabolites in a low-iron
environment.
Correlations of Metabolite Levels with the
Microbiome
It is conceivable that the changes in microbial metabolism
can result from an altered microbiome composition. However,
microbial metabolism may, in theory, also respond to iron
without a change in abundances of certain taxa. As a first attempt
to link changes in the microbiome composition to the marked
changes in microbial metabolism we aimed to correlate SCFA,
butyrate, propionate, acetate, BCFA and ammonia levels with
the relative abundance of bacterial taxa of the microbiome as
analyzed by 16S rDNA pyrosequencing.
Short Chain Fatty Acids
Butyrate levels were positively correlated with Roseburia and
Coprococcus, which both are known for the production of
butyrate, and with Clostridiales, while Bifidobacterium correlated
negatively (Figures 5A–D). Propionate correlated with Prevotella
and Dialister, and was inversely correlated with Pediococcus and
Lactobacillaceae (Figures 5E–H). Acetate levels could be
correlated to Bacteroidales and were inversely correlated
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FIGURE 4 | Effect of iron on organic acid levels associated with proteolytic or polyphenol metabolism and on organic acids with siderophoric activity.
Concentrations (mean+range) of phenylpropionate, 4-hydroxy-phenylpropionate and phenylacetate at 72 h are displayed relative to the lowFe condition which was set
at 100%. §We note that phenylacetate levels included traces of glycerol in one biological replicate of 50FeS, 250FeS, and FeH, but which were negligible amounts
relative to the phenylacetate levels (A). Concentrations (mean+range) of metabolites with siderophoric activity; 2-hydroxy-isovalerate, 2-hydroxy-isocaproate, and
phenyllactate at 72 h are displayed relative to the lowFe condition which was set at 100%. §We note that phenyllactate levels included negligible traces of a unknown
metabolite in 1 biological replicate of 50FeC and FeH. Means (n = 2; compared by Tukey’s multiple comparison post-hoc test) of the same metabolite without a
common letter differ significantly (p < 0.05) (B).
FIGURE 5 | Bacterial taxa that correlate with luminal acetate, butyrate, and propionate levels. The relative abundance (fraction of the total 16S rDNA; e.g.,
0.01 = 1%) of bacterial taxa in all samples at 24 and 72 h (n = 24) (as determined by 16S rDNA pyrosequencing) was correlated with luminal butyrate (A–D),
propionate (E–H), and acetate (I–L) levels in the same samples. Best fit lines with 95% confidence bands were generated by linear regression analysis. Spearman
r- and p-value are displayed for each graph. This figure shows the taxa that correlated best, additional taxa are shown in Supplementary Figure 7.
to Desulfovibrionales, Clostridiales and Enterobacteriaceae
(Figures 5I–L). The sum of luminal butyrate, propionate
and acetate levels in the lumen at 24 and at 72 h correlated
positively with Roseburia, and was inversely correlated with
Bifidobacteriaceae (Supplementary Figure 7). Spearman r and
p-value of a Spearman rank test are depicted within the figures.
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Branched Chain Fatty Acids and Ammonia
The level of the proteolytic metabolites ammonia and BCFA
could be correlated to the following taxa. Lachnospiraceae
(among which were Roseburia and Coprococcus) were strongly
correlated with BCFA levels, and also Oscillibacter, Clostridiales,
Desulfovibrionales, and Enterobacteriaceae correlated positively
with BCFA levels. Conversely, Pediococcus, Lactobacillaceae,
and Enterococcaceae were inversely correlated (Figure 6).
Similar results were found for cumulative ammonia levels as
they strongly correlated with Lachnospiraceae (among which
were Roseburia and Coprococcus), and also with Clostridiales,
Desulfovibrionales, Oscillibacter, Enterobacteriaceae, and
Dialister. Furthermore, cumulative ammonia levels were
inversely correlated with Pediococcus, Bacteroides and
Lactobacillaceae (Supplementary Figures 8A–K).
Metagenomic Analysis: Mapping the
Metabolome to the Metagenome
To deduce where the changes in microbial metabolism may
originate from, we correlated the relative abundance of bacterial
taxa to metabolite levels, and moreover, we linked the metabolite
levels to metabolic pathways identified in the metagenome.
Furthermore, metagenomic analysis allowed us to explore what
other functions and hallmarks were over- or underrepresented in
the lowFe and 50FeS microbial communities.
General Metagenomic Annotations
To investigate the effect of iron on the functional potential
of the gut microbial community, we analyzed a total of 69.9
and 59.8 million quality trimmed metagenomic sequencing
read pairs (average single end read length: 207 base pairs)
for the lowFe and 50FeS replicates at 72 h, respectively. A
total of 43.2 million sequences (32.5%) were aligned to the
human gut microbial gene catalog (Qin et al., 2010) allowing
them to be functionally characterized in terms of the SEED
subsystems and KEGG orthology annotations An overview of
the functional composition (SEED subsystems) of the lowFe and
50FeS conditions is shown in Supplementary Figure 9.
The functions that were most strongly affected by the iron
treatment were related to the “Motility and Chemotaxis” level-1
subsystem, that was overrepresented in 50FeS compared to lowFe
(2log ratio: 0.40; p = 0.044). The more detailed annotations
provided by the SEED level-2 subsystems showed that this
could be attributed to the categories “Flagellar Motility” (2log
ratio: 0.80; p = 0.053), “Flagellum” (2log ratio: 0.67; p =
0.054) and “Bacterial Chemotaxis” (2log ratio: 0.19; p = 0.091;
Supplementary Table 4). Moreover, this was also supported by
the many flagellar and chemotaxis related KEGG orthologs that
were significantly enriched in 50FeS (Supplementary Table 5).
One subsystem of special interest in the context of this study
was “Iron Acquisition and Metabolism.” Although there was no
net difference found of the level-1 subsystem, we found that the
level-2 subsystem “Transport of Iron” was enriched in the 50FeS
condition (2log ratio: 0.34; p = 0.001; Supplementary Table
4), as may be expected for the condition with supplementary
iron.
Saccharolytic and Proteolytic Related Subsystems
With metagenome analysis we aimed to link the marked
metabolic changes described above to the enrichment or
depletion of SEED subsystems and KEGG orthologs to find
out which mechanisms were possibly responsible for the
metabolic changes. This is rather complex as many enzymatic
systems can work in two directions and because the balance
FIGURE 6 | Bacterial taxa that correlate with BCFA levels. The relative abundance (fraction of the total 16S rDNA; e.g., 0.01 = 1%) of bacterial taxa in all samples
at 24 and 72 h (n = 24; as determined by 16S rDNA pyrosequencing) was correlated with the sum of isobutyrate and isovalerate (collectively called BCFAs) levels in the
same samples. (A–E) Show positive correlations while (F–H) show inverse correlations. Best fit lines with 95% confidence bands were generated by linear regression
analysis. Spearman r-and p-value are displayed for each graph. This figure shows the taxa that correlated best, additional taxa are shown in Supplementary Figure 8.
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in microbial production and utilization of metabolites is often
difficult to predict. This analysis nevertheless provided some
clues which might explain part of the metabolic pattern
as we observed in the lumen/dialysate. Metabolite analysis
pointed at a shift from carbohydrate fermentation toward
protein fermentation upon iron supplementation. Subsystem
data showed that the level-2 subsystem “Protein Degradation”
was enriched in 50FeS (2log ratio: 0.39; p = 0.008). This involved
enrichment of aminopeptidases (EC 3.4.11.x) (KEGG orthologs;
Supplementary Table 5), which may be involved in exogenous
protein fermentation. Carbohydrate related subsystems that
may support a decreased carbohydrate fermentation include
level-2 subsystems “Fructooligosaccharides (FOS) and Raffinose
Utilization” (2log ratio: −0.20; p = 0.071) and “Beta-glucoside
Metabolism” (2log ratio: −0.64; p = 0.022), both of which were
reduced in 50FeS (Supplementary Table 4). The apparent shift
toward a proteolytic profile was characterized by an increase in
ammonia, BCFA and aromatic metabolites. We attempted to link
these specific changes to the subsystems and KEGG orthologs as
specified below.
Ammonia related subsystems
Level-1 subsystem “Amino Acids and Derivatives” showed that
its level-2 subsystems “Lysine Degradation” (2log ratio: −0.25;
p = 0.045) was underrepresented in 50FeS, while “Tryptophan
Synthesis” and “Cysteine Biosynthesis” were enriched (2log ratio:
0.41; p = 0.005 and 0.36; p = 0.012, respectively). This
would typically lead to decreased amounts of ammonia, but in
contrast, “Glutamate Dehydrogenase” (2log ratio: −0.28; p =
0.061) and “Glutamine Synthetases” (2log ratio: −0.36; p =
0.106), which may assimilate ammonia, were underrepresented
in 50FeS. Additionally, subsystem “Ammonia Assimilation”
was underrepresented in 50FeS (2log ratio: Ammonia related
subsystems 0.24; p = 0.037) which could fit with the increase of
ammonia in this condition (Supplementary Table 4). Annotation
of themetagenomic sequencing reads to KEGGorthologs showed
that nitrogen fixation genesNifA andNifBwere enriched in 50Fe,
which also fits with increased levels of ammonia (Supplementary
Table 5).
Branched Chain Fatty Acid-related subsystems
Level-1 subsystem “Amino Acids and Derivatives” showed
that its level-2 subsystem “Ketoisovalerate Oxidoreductase” was
enriched in 50FeS (2log ratio: 0.45; p = 0.050; Supplementary
Table 4). This ferredoxin-type enzyme is involved in the
degradation of valine, leucine and isoleucine degradation which
can result in the production of BCFAs. Annotation of the
sequences to KEGG orthologs also showed that ketoisovalerate
oxidoreductase (EC 1.2.7.7) was enriched in the 50FeS condition
compared to lowFe (Supplementary Table 5).
Aromatic compounds related subsystems
Level-1 subsystem “Amino Acids and Derivatives” showed that
its level-2 subsystem “Aromatic Amino Acid Interconversions
with Aryl Acids” was enriched in 50FeS (2log ratio: 0.76; p =
0.040). This ferredoxin-type system converts aromatic amino
acids to aryl acids, among which is phenylacetate and possibly
also other phenylalanine derivatives like phenyllactate and
phenylpropionic acid. Similarly, level-1 subsystem “Metabolism
of Aromatic Compounds” showed an enrichment of the level-
2 subsystem “Aromatic Amin Catabolism” (2log ratio: 0.55;
p = 0.088) which may have contributed to the higher levels of
phenyl derivatives in the 50FeS condition. In contrast, subsystem
“Homogentisate Pathway of Aromatic Compound Degradation”
was mildly underrepresented in 50FeS (2log ratio: −0.27; p =
0.014; Supplementary Table 4).
Cytotoxicity of the Fecal Water
Based on the metabolome data, the toxicity of the fecal water was
increased with iron, especially in the ferrous sulfate conditions.
To confirm this, the cytotoxicity of the 50FeS dialysate toward
a tight monolayer of intestinal epithelial Caco-2 cells was
assessed. These cytotoxicity tests comprised multiple readouts,
i.e., monitoring of the trans epithelial electrical resistance (TEER)
(cellular monolayer integrity), phenol red permeability (cellular
monolayer permeability), lactate dehydrogenase (LDH) release
(cell cytotoxicity), and trypan blue staining (cell death). To
exclude the effect of iron itself on the cells, iron was removed
from all dialysates prior to the cytotoxicity analyses. Monitoring
of TEER showed a deteriorating effect of the dialysis liquids
(before exchange in TIM-2) and dialysates (after exchange;
sampled at 72 h) in the TIM-2 system when compared to a
standard maintaining buffer. Remarkably, the 50FeS dialysate at
72 h showed a larger relative TEER decrease compared to the
lowFe dialysate at 72 h (Figure 7A). The slopes as analyzed by
linear regression were significantly different (p = 0.002). Also
note that the lowFe conditions before and after exchange in
the TIM-2 system show similar results. Phenol red permeability
confirmed these findings as the permeability of the Caco-2
monolayer was shown to be increased after exposure to 50FeS
dialysate at 72 h compared to lowFe dialysate at 72 h (p =
0.008) (Figure 7B). The decrease in epithelial integrity may be
caused by a loss of junction proteins and/or direct toxicity to
the cells. Analysis of LDH release and trypan blue staining point
at increased cell cytotoxicity and cell death (p = 0.081 and
p = 0.067 respectively; Supplementary Figure 10), but initial loss
of junction proteins may also add to the effect.
DISCUSSION
To find solutions for the unwanted side effects of oral iron
administration, such as diarrhea and increased gut inflammation,
it is important to investigate the effects of iron on the gut
microbiota composition and metabolic activity. Although several
studies have reported on the effects of iron on gut microbiota
composition, the effects of iron on gut microbial metabolism
and its functional potential has remained largely unexplored.
We hypothesize that supplementary iron adversely affects gut
microbiota composition, and that it may increase microbial
protein fermentation and production of SCFAs. It is the first
exploration that reports on the effect of multiple iron sources
and doses on the microbiome composition, metagenome, and
that included profiling of the effects of these iron interventions
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FIGURE 7 | Toxicity of the microbial metabolome for an intestinal monolayer. Effect of dialysis liquids (before exchange in TIM-2; not containing microbial
metabolites) and dialysates (after exchange in TIM-2; at 72 h) of the lowFe condition and 50FeS condition on the integrity and permeability of a Caco-2 monolayer.
Epithelial integrity is displayed as relative transepithelial electrical resistance (TEER) which was regularly recorded during 7 h incubation. HBSS was used as a standard
maintaining buffer which should keep the TEER at a constant high level. The decrease in epithelial integrity of the 50FeS dialysate was significantly faster compared to
the lowFe dialysate as analyzed by linear regression. We note that iron was removed from the dialysis liquids and dialysates prior to applying them to the epithelial
monolayers (A). Epithelial permeability as determined by the flux of phenol red from the apical side to the basolateral side, analyzed by an unpaired t-test (B).
**p < 0.01 n = 3 for the dialysis liquids before exchange in TIM-2 and n = 6 for the dialysates after exchange; at 72 h in TIM-2.
on the microbial metabolome in both an explorative and targeted
manner.
Preparation of the Microbiota and its
General Characteristics in the TIM-2 Model
The present study was done in an in vitro model for the human
colon. It has been observed that models such as TIM-2 can
effectively maintain a stable gut microbiota similar to the donors
fromwhom it was prepared, and that alsomimics its functionality
(Kovatcheva-Datchary et al., 2009; Rajilic-Stojanovic et al., 2010;
Maathuis et al., 2012). Notably, the studies in TIM-2 include a
control setup operated in parallel with the test experiments to
ensure that the changes observed originate from the treatments
itself. A standardized inoculum that is derived from a pool of
subjects is generally used in this system, but the use of either
a pool of donors or a single donor remains debatable among
experts (Kovatcheva-Datchary et al., 2009; Rajilic-Stojanovic
et al., 2010; Maathuis et al., 2012). It is questioned whether
a pooled inoculum is representative for the abundance and
the variety of bacterial species, and their interactions, in the
human colon. Consequently, the use of an individual or a mixed
inoculum is believed to lead to a degree of variation among
experiments. Nevertheless, pooling was done with the purpose
of working with a standardized microbiota that can be used for
multiple different experiments, and a more diverse population
of bacteria that is more representative microbiota for the whole
population. In a recent study in TIM-2, we demonstrated that
the use of a pool of microbiota for in vitro studies does not
result in a bacterial community with an aberrant profile and
metabolic activity compared to that normally obtained from
single donors (Aguirre et al., 2014). Notably, it was previously
reported that the effect of arabinoxylan and inulin on an
inoculum prepared from pooled fecal samples (in TIM-2) and
from an individual volunteer (in SHIME; Simulator of the
Human Intestinal Microbial Ecosystem; another in vitro colon
model) showed a similar metabolic activity of the microbiota in
both setups (Van den Abbeele et al., 2013). Therefore, we are
convinced that a single pooled inoculum as applied herein (n =
1, TIM-2 run in duplicate), is a justified and cost-efficient strategy
to profile the effects of a dietary substance on gut microbiota
composition and activity in an in vitro system.
Supplementary Iron Induces a Shift Toward
a Less Favorable Microbiota Composition
As expected, iron had a marked effect on microbiome
composition. Our data indicate that the high iron doses had
an additional effect compared to the medium iron doses.
Interestingly, the ferrous sulfate and ferric citrate conditions
had a very similar effect on the gut microbiota composition.
Comparison of the relative abundance of single bacterial taxa
between groups showed that the most apparent differences were
the lower relative abundance of Streptococcus, Lactobacillus, and
Bifidobacterium with supplementary iron, which is roughly in
line with previous studies for at least the latter two taxa (Kortman
et al., 2014). Notably, Bifidobacterium and Lactobacillus are
generally considered beneficial members of the gut microbiota.
Interestingly, in our model several other members of the
lactic acid bacteria group (to which Lactobacillus belongs),
i.e., Streptococcus, Pediococcus, and Enterococcus also showed
a decreased relative abundance in response to iron. We did
however not observe an increase in Enterobacteriaceae or closely
related taxa, which was frequently observed in former in vivo
studies (Mevissen-Verhage et al., 1985; Balmer et al., 1989;
Benoni et al., 1993; Lee et al., 2008; Zimmermann et al.,
2010; Jaeggi et al., 2014). This could suggest that an increase
in Enterobacteriaceae depends on host inflammatory responses
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which they can exploit to their own benefit (Winter et al.,
2013). Another explanation that we cannot exclude, is that the
specific composition of the here used adult fecal microbiota of
Dutch volunteers, which is different from the above mentioned
infant or animal microbiota in previous studies, might inhibit
overgrowth of this taxon. Instead, we found increased levels
of the genera Roseburia, Coprococcus, Oscillibacter, Prevotella,
and Desulfovibrio. We also report that the relative abundance
of certain Bacteroides species was increased with 50FeS. Among
these was B. fragilis, an opportunistic and potent pathogen, but
that is also important in shaping our immune system (Wexler,
2007). Finally, it appeared from our study that Archaea tend
to increase with ferrous sulfate, with Methanosphaera being
the most significant taxon. Archaea could be involved in the
pathogenesis of intestinal diseases, but it was also proposed
that their presence is a sign of a healthy gut, because they
can thrive on health promoting bacterial metabolites such
as SCFAs and formate (Jarrell et al., 2011; Matarazzo et al.,
2012).
Supplementary Iron Induces a Metabolic
Shift Toward a Proteolytic and More Toxic
Profile
The microbiome composition moved slightly toward a less
favorable profile, but the most prominent effect under iron-
rich conditions was the change of the microbial metabolome
from a saccharolytic to a proteolytic profile. Lactate and formate
levels were much lower in all conditions with supplementary
iron compared to lowFe, also ethanol levels were decreased and
succinate levels were decreased in the highFe conditions. These
metabolites are primarily derived from carbohydrate, and levels
of lactate and formate being the highest in the lowFe condition
are consistent with previous findings of an in vitro study of Dostal
et al. under extremely low iron conditions (Dostal et al., 2012b).
Despite the apparent decrease in saccharolytic activity with iron
in our model, the production of the mainly carbohydrate derived
SCFAs was not decreased, probably due to the fact that they
can also be produced from protein (Macfarlane and Macfarlane,
2012). More specifically, acetate and butyrate levels did not
differ significantly compared to lowFe, but propionate levels were
higher in the highFe conditions. This is partially in line with
previous in vivo and in vitro findings of Dostal et al., although
their data from different models were not always consistent at
this point (Dostal et al., 2012a,b, 2014b).
In our model, the increased proteolytic activity under iron-
rich conditions was evident by the increased levels of ammonia
(a toxic metabolite), BCFAs and valerate, which are all protein
fermentation-related metabolites (Smith and Macfarlane, 1997;
Hughes et al., 2008; Hoyles and Wallace, 2010; Macfarlane and
Macfarlane, 2012; Nery et al., 2012; Nyangale et al., 2012).
The iron-induced switch toward a more proteolytic profile is
further supported by the tendency that aromatic metabolites
were increased. Importantly, it is well known that protein
fermentation in general results in the formation of a putrefactive
and toxic environment (Macfarlane and Macfarlane, 2012;
Nyangale et al., 2012).
Our present study shows for the first time that the microbial
metabolites that are produced under iron-supplemented (50FeS)
conditions are indeed harmful to an in vitromonolayer of human
intestinal epithelial cells. This was not evident from previous
studies, but which may be explained by a different design and the
use of different gut-model and cell-systems (Dostal et al., 2012b,
2014a).
Supplementary Iron Induces an Enrichment
of Certain Virulence-Associated Pathways
Increased iron availability has been associated with an increase
in virulence of bacterial pathogens (Bullen et al., 2005; Kortman
et al., 2012). This inspired us to look into the abundance of
virulence associated subsystems in ourmetagenome data. Flagella
enable microbes to swim and swarm over surfaces and can be
involved in adhesion to epithelial cells, which make them an
important virulence factor (Moens and Vanderleyden, 1996).
Intriguingly, our results show that the level-1 subsystem “Motility
and Chemotaxis” was enriched in the 50FeS condition. Level-
2 subsystems not only showed that flagella related subsystems
were enriched in 50FeS, but also bacterial chemotaxis. Thus, iron
could provide motile and chemotactic enteric pathogens with
a competitive advantage over other members of the microbiota
under iron-rich conditions.
Possible Explanations for the Iron-Induced
Shift in Microbial Metabolism
Our metabolome data represent a steady state situation that
is the result of both metabolite production and consumption.
Cross-feeding of microbial metabolites is anticipated to have
a large influence on the metabolome composition (Nyangale
et al., 2012; Rajilic-Stojanovic, 2013). Based on our 16S rDNA
pyrosequencing and metagenomic data, and literature we can
however provide specific leads for the explanation of the iron-
induced changes in gut microbial metabolic activity. First of all,
many metabolic pathways rely on the action of iron-dependent
enzymes (ferredoxin-type enzymes with iron-sulfur clusters),
for instance in the Wood-Ljungdahl pathway, and may thus
be influenced by iron supplementation (Ragsdale and Pierce,
2008; Hood and Skaar, 2012). Secondly, redox balance needs to
be maintained and microbial fermentation is regulated by this
balance (Macfarlane and Macfarlane, 2003). It can be envisaged
that supplementary iron has a large impact on the redox balance
as this transition metal is able to function as an electron
donor and electron acceptor. Importantly, also the availability
of carbohydrates has a large impact on the type of metabolites
that will ultimately be produced. Interestingly, when sufficient
carbohydrate is present there is a decreased need to decarboxylate
succinate to produce propionate, as has been observed for
certain Bacteroides spp. (Macfarlane and Macfarlane, 2003).
This fits with our findings that levels of succinate decreased
while propionate levels increased in the high-iron conditions,
indicating that carbohydrate sources were depleted early in the
iron-rich conditions. Early depletion of carbohydrate sources by
the gut microbiota in the conditions with supplementary iron
may also clarify the increase in proteolytic activity. Furthermore,
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it may explain the low levels of lactate in the iron-supplemented
conditions, but this might also be attributed to the lower
abundance of lactic acid bacteria in the same conditions. An iron-
induced increase in protein fermentation has previously also been
observed in another in vitro colon model (Dostal et al., 2012b).
This iron-induced shift toward a proteolytic profile has now been
confirmed and studied in more detail. Carbohydrate substrates
could have been limiting in the iron-supplemented conditions
in the in in vitro models. It needs to be investigated whether
carbohydrate sources become depleted early indeed, and whether
this can also happen in the in vivo situation.
Although, the iron sources ferrous sulfate and ferric citrate
differed in their counter-anion and initial valence state of
the iron, they appeared not to cause marked differences in
microbiome composition. However, differential results were
observed on gut microbial activity and it appeared that the
metabolic profile of the ferric citrate conditions was less
proteolytic compared to the ferrous sulfate conditions. We
however did not compare the in vitro cytotoxicity of the ferric
citrate conditions with the ferrous sulfate conditions. Inorganic
anions such as sulfate can affect microbial fermentation as
these anions can function as an electron sink (Macfarlane and
Macfarlane, 2003). Although the contribution of sulfate in the
condition with ferrous sulfate was relatively small compared to
the amount of sulfate already present in the SIEM and dialysis
liquid (2.5–12.3% of the amount of sulfate present as magnesium
sulfate), the additional sulfate may have influenced microbial
metabolism. The citrate in the ferric citrate condition might have
formed an alternative carbon source, but the contribution of
citrate to the amount of carbon sources already present is also
relatively small. Notwithstanding their biochemical differences,
both ferrous sulfate and ferric citrate caused a shift toward a
proteolytic profile.
Correlations of metabolite levels with the relative abundance
of bacterial taxa do not provide a causal relationship but may
provide some indication which taxa are responsible for the
differences observed. It is interesting to see that Prevotella,
whose growth was stimulated with iron, was positively correlated
with propionate levels. Prevotella may drive the conversion
of succinate to propionate (Nyangale et al., 2012), especially
when carbon sources are limiting (as discussed above). From
literature it is well-known that Roseburia and Coprococcus (both
belong to the Lachnospiraceae family) and Faecalibacterium
are producers of butyrate (Louis and Flint, 2009). Indeed we
found a strong positive correlation of Roseburia and Coprococcus
with butyrate levels, but butyrate levels do not correlate with
Faecalibacterium. So far, very little is known about gut microbiota
members that convert amino acids to BCFA. Suspected members
are Clostridium spp. and Atopobium, but only Clostridium
coccoides has previously been correlated with fecal BCFA levels
(Thompson-Chagoyan et al., 2011; Rajilic-Stojanovic, 2013).
Two groups of bacteria that are generally associated with
proteolytic activity are Bacteroides and Clostridium (Cummings
and Englyst, 1987; Nyangale et al., 2012), and although iron
may theoretically have induced their metabolic activity, their
abundance did not significantly change in our system. Candidate
taxa that were identified in this study are Lachnospiraceae,
Oscillibacter, Clostridiales, and Desulfovibrionales as they all
positively correlated with BCFA and ammonia levels. Thus,
Lachnospiraceae not only correlated with butyrate levels, but
also strongly correlated with the BCFA and ammonia levels in
our study, which has not been described before. Enrichment or
depletion of certain genetic characteristics in the metagenomic
data also provided clues about themicrobial pathways involved in
the iron-induced changes in gut microbial metabolism. The most
obvious findings involved the protein- and amino acid related
subsystems, such as “Protein Degradation,” “Ketoisovalerate
Oxidoreductase,” “Aromatic Amino Acid Interconversions with
Aryl Acids,” and “Aromatic Amin Catabolism” which were
enriched in the 50FeS condition compared to the lowFe
condition. It is interesting to note that the enzyme ketoisovalerate
oxidoreductase needs iron as a cofactor, and is not only present
in bacteria, but also in Archaea (Heider et al., 1996). This
may indicate that also Archaea contributed to the iron-induced
production of BCFAs.
Supplementary Iron Decreases the
Abundance of Siderophoric Metabolites
Another intriguing aspect of our findings concerned the
identification of the bacterial metabolites 2-hydroxy-isovalerate
and 2-hydroxy-isocaproate that have siderophoric activity
(Drechsel et al., 1993). The lowFe and hemin (an iron source
that requires a different bacterial uptake mechanism Andrews
et al., 2003) conditions had a lower total iron content compared
to the mediumFe and highFe conditions. Indeed, levels of the
iron-binding acids were relatively high in the lowFe and hemin
conditions, while they were low or absent in the medium and
high-iron conditions. This fits with the idea that bacteria only
produce siderophores when readily available iron is scarce. We
cannot be sure that these low affinity siderophoric metabolites
indeed acted as siderophores, but as the levels of these aromatic
amino acid-derived siderophores oppose the trend of the other
aromatic amino acid-derived metabolites levels, our results
suggest that limitation of iron may have triggered the production
of these acids for at least a subset of the gut microbiota.
CONCLUDING REMARKS
In conclusion, this study shows that the provision of iron
(provided as ferrous sulfate or as ferric citrate) to an in vitro
human gut microbiota resulted in (i) a lower relative abundance
of bacteria that are generally considered beneficial, (ii) an
increase in toxic metabolites that impair the barrier function
of cultured intestinal epithelial cells, (iii) and an increase in
bacterial virulence-associated pathways. Thus, supplementation
of these forms of iron creates a more hostile environment in
the absence of host influences and under the conditions tested.
The combination of these three effects could increase the risk
for enteric infections. In vivo, the host immune status and the
composition of the gut microbiota will largely determine whether
or not an intestinal infection will become apparent. Our data
also indicate that iron limitation increases the production of
bacterial metabolites with iron-binding features. If and how
these metabolites act as siderophores and mediate bacterial iron
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uptake under these conditions remains to be determined. One
future challenge that remains, is to pinpoint metabolic changes
to particular microbes, for which we provide novel leads in the
present study. To generate better insight in the effects of iron
on the actual microbial metabolism and to be able to pinpoint
these metabolic properties to certain taxa, a metatranscriptomic
approach is needed. This may be complemented with e.g., a LC-
MS, HPLC, and/or NMR spectroscopy metabolomics approach
to identify and quantify additional microbial volatile and non-
volatile metabolites (Nyangale et al., 2012). Together this will
help us in identifying microbial taxa that are responsible for
the adverse effects in response to supplementary iron, and
consequently, in developing an iron preparation that is highly
available to humans, but has little to no adverse effects on the
gut microbiota composition and metabolism. To reduce the
risk for unwanted side effects this is an important challenge
that remains in combating anemia in underdeveloped infection
endemic regions.
MATERIALS AND METHODS
Origin of the Microbiota
The microbiota for the TIM-2 experiments consisted of an active
fecal microbiota of 6 Dutch adult volunteers [male: n = 3, age =
32.7 (21–39); female: n = 3, age = 33.3 (28–41)]. The healthy
individuals were non-smokers and had not used antibiotics,
prebiotics, probiotics or laxatives 3 months prior to the donation.
Fecal samples were collected, kept in an anaerobic environment
and were proceeded quickly to mixing and homogenization in
an anaerobic cabinet. Mixed stools were used in a fed batch
fermentor simulating the “cecum” conditions as described by
Maathuis et al. (2012). Briefly, 670ml medium without the
addition of iron and hemin was inoculated with 80 g of mixed
stools and incubated for 44 h at 37◦C and under anaerobic
conditions by a gaseous nitrogen flux, with fed-batch addition of
1250ml medium over time. The composition of the microbiota
after this batch fermentation was similar to the microbiota
composition just after mixing the individual fecal samples (data
not shown). Glycerol (10% final concentration) was added to the
resulting fed-batch culture, that was aliquoted and snap-frozen in
liquid nitrogen and stored at−80◦C before inoculation in TIM-2.
It has also previously been shown that these standardized samples
are similar in composition and activity of a fresh fecal sample
(Minekus et al., 1999; Venema et al., 2000; Kovatcheva-Datchary
et al., 2009; Aguirre et al., 2015).
Dynamic In vitro Model of the Large
Intestine (TIM-2)
TNO’s in vitro model of the proximal large intestine (TIM-2)
accurately simulates the average physical and dynamic conditions
in the human proximal colon and has been described in detail
before (Minekus et al., 1999; Maathuis et al., 2009; Rehman
et al., 2012). TIM-2 is characterized by a physiological water
content and constant removal of metabolites via a dialysis
system, simulating host uptake, maintaining physiological levels
of these metabolites, and allowing metabolite production kinetics
to be recorded. This makes the model well suited to study
both microbial composition and metabolic activity (Minekus
et al., 1999; Venema et al., 2000). In short, the tightly computer
controlled model consisted of glass units with a flexible wall
inside through which peristaltic movements were achieved
regularly. This way the lumen was mixed and transported
through the system. Temperature was set at 37◦C and the pH
at 5.8 (simulating the pH in the proximal colon), controlled
with a pH sensor in combination with secretion of sodium
hydroxide. A dialysis system consisting of semipermeable hollow
fibers was running through the lumen. A flow of dialysis
liquid through the dialysis system constantly removed water and
fermentation products. Therefore, physiological concentrations
of small molecules, such as electrolytes, were retained and
accumulation of microbial metabolites was prevented. A constant
volume of the luminal content was maintained by water
absorption controlled by a level sensor. The system was kept
anaerobic by flushing with gaseous nitrogen. This resulted in the
growth of a highly active and densemicrobiota, previously shown
to be comparable to that found in the human proximal colon
(Minekus et al., 1999; Venema et al., 2000; Kovatcheva-Datchary
et al., 2009).
Standard Ileal Efflux Medium (SIEM) and
Dialysis Liquid Composition
Standard ileal eﬄux medium (SIEM) was slightly modified for
experiments in TIM-2 compared to the medium which was
described by Gibson et al. (1988), mainly concerning a higher
concentration of carbohydrates, pepton, casein and Tween 80
(Minekus et al., 1999; Van Nuenen et al., 2003). For the purpose
of our experiments we removed the standard iron sources
(0.009 g/L FeSO4.7H2O and 0.02 g hemin g/L) from the SIEM
formulation to produce a non-iron supplemented lowFe control.
Notably, it still contained low amounts of endogenous iron
sources that come with the other ingredients. SIEM contained
the following components (g/L): 9.0 pectin, 9.0 xylan, 9.0
arabinogalactan, 9.0 amylopectin, 43.7 casein, 74.6 starch, 31.5
Tween 80, 43.7 bactopepton, 0.7 ox-bile, 4.7 g K2HPO4.3H2O,
8.4 g NaCl, 0.7 g MgSO4.7H2O, 0.8 g CaCl2.2H2O, and 0.3 g
cysteine.HCl, plus 1.5ml of a vitamin mixture containing (per
litre): 1mgmenadione, 2mgD-biotin, 0.5mg vitamin B12, 10mg
pantothenate, 5mg nicotinamide, 5mg p-aminobenzoic acid,
and 4mg thiamine. The pH was adjusted to 5.8. Low iron
dialysis liquid contained (per litre): 2.5 g K2HPO4.3H2O, 4.5 g
NaCl, 0.5 g MgSO4.7H2O, 0.45 g CaCl2.2H2O, 0.05 g bile, and
0.4 g cysteine.HCl, plus 1ml of a vitamin mixture as mentioned
above. The pH was adjusted to 5.8. All medium components
were provided by Tritium Microbiology (Eindhoven, The
Netherlands). SIEM did not require pre-digestion. For the
experiments the iron sources as described below were added to
the SIEM and dialysis liquid.
TIM-2 Experiments and Test Conditions
Experiments were carried out as described before (Maathuis
et al., 2012). At the start of each experiment, the model
was inoculated with approximately 30mL of the standardized
microbiota (that was used for each experiment, in duplicate)
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and 80mL of dialysate. The microbiota was allowed to adapt
to the model conditions for 16 h. Then a 3-day experimental
period was started. Interventions with iron were as follows:
(i) no additional iron (lowFe), (ii) 50µmol/L ferrous sulfate
(50FeS), (iii) 250µmol/L ferrous sulfate (250FeS), (iv) 50µmol/L
ferric citrate (50FeC), (v) 250µmol/L ferric citrate (250FeC),
and (vi) 50µmol/L hemin (FeH). The experiments with addition
of ferrous sulfate and ferric citrate were designed to mimic
oral iron supplementation in medium and high amounts, and
also to investigate whether these different iron sources have
differential effects on microbial composition and metabolism.
Although hemin will not be used as an oral iron supplement, we
included this iron source as an additional condition to investigate
how the gut microbiota responds to an iron source that that
requires a different uptake mechanism. Iron was added to the
lumen at t = 0, 24, and 48 h and was also provided in the
constant flow of dialysis liquid to prevent loss of iron from the
lumen. While the lowFe condition can be regarded as mildly
iron-deficient, the mediumFe and highFe can be best described
as iron-supplemented conditions. The effective iron content of
the TIM-2 lumen during our experiments, compared to in situ
iron content of human feces, is shown in Supplementary Data
1. Samples were taken from the lumen and from the dialysate
starting after the adaptation period (set as time point 0) and at
8, 24, 32, 48, 56, and 72 h after starting the iron intervention.
These were used to determine microbiota composition, levels of
iron, SCFA, BCFA, ammonia, and to profile the metabolome by
1H-NMR spectroscopy and GC-MS organic acid analysis. After
24 and 48 h, a total lumen sample of 25mL was removed from
the system to simulate passage of material from the proximal
to the distal colon. This way a physiological colonic transit
time of 48 h was mimicked. In each experiment, SIEM was
fed during the 3-day experimental period with 60mL/day and
contained the iron source and concentration corresponding to
the applied conditions. Figure 8 shows the experimental scheme
and summarizes the analyses there were done on the various
samples.
SCFA/BCFA Quantification in Lumen and
Dialysate Samples
Samples (t = 0, 24, 48, and 72 h) were centrifuged for
5min at 12,000 g and a mixture of formic acid (20%),
methanol and 2-ethyl butyric acid (internal standard, 2mg/ml
in methanol) was added to the clear supernatant. A 0.5µl
sample was injected on a GC-column (Stabilwax-DA, length
15m, ID 0.53mm, film thickness 0.1mm; Varian Chrompack,
The Netherlands) in a Chrompack CP9001 gas chromatograph
using an automatic sampler (Chrompack liquid sampler CP9050;
Varian Chrompack). Specifically, concentrations of acetate,
propionate, butyrate, valerate, isovalerate, and isobutyrate were
determined (Maathuis et al., 2009).
Ammonia Quantification in Lumen and
Dialysate Samples
Samples (t = 0, 24, 48, and 72 h) were centrifuged for 5min
at 12,000 g. Ammonia in the supernatant was determined based
on the Berthelot reaction, in which ammonia first reacts with
alkaline phenol and then with sodium hypochlorite to form
indophenol blue. The absorbance of the indophenol blue is
directly proportional to the original ammonia concentration and
is measured at 660 nm. The measurement was automated on a
Cobas Mira Plus autoanalyzer (Roche, Almere, The Netherlands)
and was performed by Bio-aNAlytiX (Mook, the Netherlands).
FIGURE 8 | Scheme of the experimental setup and overview of sample analysis. Experimental setup and workflow of the TIM-2 experiments, and a table that
shows what type of analyses were performed on which samples.
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Concentrations in the samples were determined via comparison
with a series of standard solutions with known concentrations
(Maathuis et al., 2009).
1H-NMR Spectroscopy of Dialysate
Samples
Dialysate samples of lowFe, 50FeS, 250FeS, FeH and 50FeC at
72 h were measured with 1D and 2D COSY NMR spectroscopy.
250FeC was not analyzed because of expected interference of
large amounts of H in the citrate. A small volume (20µl) of
20.2mM trimethylsilyl-2,2,3,3-tetradeutero-propionic acid (TSP,
sodium salt; Aldrich) in D2O was added to 700µl of the sample,
providing a chemical shift reference (0.00 ppm) and a deuterium
lock signal. To aid the identification of metabolites, the pH
was adjusted to 2.50 and 7.00 using concentrated HCl. Finally,
650µl of the sample was placed in a 5mm NMR tube (Wilmad
Royal Imperial; Wilmad LabGlass, USA). 1H-NMR spectra were
obtained on a Bruker Avance I 500 spectrometer, operating at
11.7 T, with a Broad Band Inverse (BBI) probehead equipped
with a actively shielded z-gradient coil. 1D 1H spectra were
acquired as 256 transients in 64K data points with a spectral
width of 10080Hz. The sample temperature was 298K; the
H2O resonance was presaturated by single-frequency irradiation
during a relaxation delay of 4 s; a pulse width of 7µs was
used (corresponded to a 90◦ excitation pulse). Shimming of
the sample was performed automatically using the Topshim
shim program (Bruker). The resonance line widths for TSP and
all metabolites were <1Hz. Phase and baseline were corrected
manually. All spectra were scaled to TSP and metabolite and
TSP resonances were fitted semi-automatically with a Lorentzian
line shape. Metabolite concentrations in the samples (pH 2.5)
were calculated to the known concentration of the TSP standard
(singlet, 9 protons) and expressed as mmol/l. Resonances were
assigned by comparison the measured data with our model
compound database containing relevant compounds (U. Engelke,
unpublished results) and the commercial available metabolite
database from Bruker (bbiorefcode-2-0-0).In the 2D COSY
spectra, the spectral widths in the F1 and F2 domains were
6002Hz. A total of 4K data points were collected in t2, 128
t1 increments with 16 transients per increment were used,
and the relaxation delay was set to 2 s. Before the Fourier
transformation, a sine-bell function was applied in both time
domains. During the relaxation delay, the water resonance
was pre-saturated.
Organic Acid Analysis of Dialysate by
GC-MS
Organic acids were analyzed using standard techniques. Briefly,
to 0.5mL of dialysate sample (72 h) 2.5mL SETH buffer
[0.25mol/L sucrose; 2mmol/L (K)EDTA; 10mmol/L Tris; 5×104
U heparin (pH 7.4)] was added. The mixture was acidified to pH2
with concentrated HCl (10%), after which the organic acids were
extracted by ethylacetate twice, derivatized with trimethylsilyl
(TMS), and analyzed on an Agilent 7890A gas chromatograph
(GC), coupled to a flame ionization detector (FID) and an
Agilent 5975C inert XL MSD mass spectrometer. Quantification
of organic acids was done by calculation of peak areas and
comparison with an internal standard (4-phenylbutyric acid).
Relative concentrations were expressed relative to the lowFe
condition which was set at 100%.
Analysis of Gut Microbial Composition,
Functions, and Metabolome Toxicity
Full descriptions of the methods used to determine luminal iron
content, microbiome composition, gut microbial functions, and
fecal water toxicity, are available in the online Supplementary
Materials and Methods.
Statistics and Data Presentation
Statistical Analysis of Total Bacteria qPCR Data,
Metabolic Data, and Cell Cytotoxicity Data
TIM-2 experiments were performed in duplicate (n = 2)
which is a small sample size, but we have previously shown that
the variations in the system are small because of the fact that
a standardized microbiota is used and because the system is
computer controlled (Venema et al., 2000). Total bacteria were
compared between time points by a paired t-test and among
the single iron conditions by a Two-way-ANOVA with repeated
measures and Bonferroni’s post-hoc test. The effects of iron on
themetabolome were compared among the single conditions, but
also as pooled data (when appropriate); mediumFe (50µmol/L
ferrous sulfate and 50µmol/L ferric citrate; n = 4) and highFe
(250µmol/L ferrous sulfate and 250µmol/L ferric citrate; n = 4).
Data from the hemin condition, a different type of iron source,
was never pooled with another condition. When two doses of
the same iron source were pooled this is indicated as FeS (both
ferrous sulfate conditions; n = 4) and FeC (both ferric citrate
conditions; n = 4). Metabolite levels, presented as mean +
range, were compared by Tukey’s multiple comparison post-
hoc test. Cytotoxicity of dialysates to Caco-2 monolayers was
tested at least in triplicate and results were expressed as mean
+ SD. The course of TEER was compared by linear regression
analysis of the slope. Means of phenol red permeability, LDH-
release and trypan blue staining data were compared by an
unpaired t-test. In case of unequal variances (as assessed by F-
test) an unpaired t-test with Welch’s correction was carried out.
Analysis was performed using GraphPad Prism version 5.03 for
Windows, GraphPad Software, San Diego California USA. P-
values < 0.05 were considered statistically significant and P-
values < 0.10 were considered as an important trend throughout
the paper.
Analysis of 16S rDNA Sequencing Data, Microarray
(I-Chip) Data, and Metagenomic Sequencing Data
Full descriptions are available in the online supplementary
materials and methods.
DATA ACCESS
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